Filing Details
- Accession Number:
- 0001181431-13-047169
- Form Type:
- 4/A
- Zero Holdings:
- No
- Publication Time:
- 2013-09-03 10:25:10
- Reporting Period:
- 2013-08-29
- Filing Date:
- 2013-09-03
- Accepted Time:
- 2013-09-03 10:25:10
- Original Submission Date:
- 2013-09-03
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1292519 | Invivo Therapeutics Holdings Corp. | NVIV | Surgical & Medical Instruments & Apparatus (3841) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1451495 | F. Sean Moran | C/O Invivo Therapeutics Holdings Corp. One Kendall Square, Suite B14402 Cambridge MA 02139 | Acting Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2013-08-29 | 28,000 | $1.23 | 28,000 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2013-08-30 | 12,000 | $1.47 | 40,000 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | P | Direct |
Footnotes
- The price reported in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.18 to $1.24, inclusive. The reporting person undertakes to provide InVivo Therapeutics Holdings Corp. ("InVivo"), any security holder of InVivo, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnotes 1 through 2.
- The price reported in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.42 to $1.49, inclusive.
- This amendment is filed to correct the transaction code applicable to the transactions reported and the related footnotes.
Billionaire Hedge Funds
